Protein kinase D mediates the synergistic effects of BMP-7 and IGF-I on osteoblastic cell differentiation

Growth Factors

Volumn 28, Issue 5, 2010, Pages 318-328

  Yeh, Lee Chuan C ^a   Ma, Xiuye ^a   Matheny Jr , Ronald W ^a   Adamo, Martin L ^a   Lee, John C ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

BMP 7; FRC cultures; IGF I; PKD

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; PROTEIN KINASE C; PROTEIN KINASE D; RECOMBINANT OSTEOGENIC PROTEIN 1; RECOMBINANT SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CATALYSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FETUS; GENETIC TRANSFECTION; HUMAN; NONHUMAN; OSTEOBLAST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CARBAZOLES; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME INHIBITORS; INSULIN-LIKE GROWTH FACTOR I; OSTEOBLASTS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RATS;

RATTUS;

EID: 77957797865     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977191003766874     Document Type: Article

References (41)

1. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB. 1990. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvarial cells. J Cell Physiol 143:213-221.
2. Asahina I, Sampath TK, Nishimura I, Hauschka PV. 1993. Human osteogenic protein-1 induces both chondroblastic and osteo-blastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol 123:921-933.
3. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP. 2002. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17:1570-1578.
4. Billiard J, Grewal SS, Lukaesko L, Stork PJ, Rotwein P. 2001a. Hormonal control of insulin-like growth factor I gene transcrip-tion in human osteoblasts: Dual actions of cAMP-dependent protein kinase on CCAAT/enhancer-binding protein delta. J Biol Chem 276:31238-31246.
5. Billiard J, Umayahara Y, Wiren K, Centrella M, Mc Carthy TL, Rotwein P. 2001b. Regulated nuclearcytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts. J Biol Chem 276:15354-15361.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Celil AB, Campbell PG. 2005. BMP-2 and insulin-like growth factor-I mediate Osterix expression in human mesenchymal stem cells via the MAPL and protein kinase D signaling pathways. J Biol Chem 280:31353-31359.
8. Chen J, Lu G, Wang QJ. 2005. Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes. Mol Pharmacol 67:152-162.
9. Ettinger SL, Lauener RW, Duronio V. 1996. Protein kinase C delta specifically associates with phosphatidylinositol 3-kinase follow-ing cytokine stimulation. J Biol Chem 271:14514-14518.
10. Friedlander GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, Laforte AJ, Yin S. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83A(Suppl 1): S151-S158.
11. Hassel S, Schmitt S, Hartung A, Roth M, Nohe A, Petersen N, Ehrlich M, Henis YI, Sebald W, Knaus P. 2003. Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes. J Bone Joint Surg Am 83A(Suppl 3): 44-51.
12. He J, Rosen CJ, Adams DJ, Kream BE. 2006. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone 38: 826-835.
13. Hogan BL. 1996. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10: 1580-1594.
14. Kim YK. 2007. TGF-β1 Induction of p21WAF1/Cip1 requires Smad-independent protein kinase C signaling pathway. Arch Pharm Res 30:739-742.
15. Kingsley DM. 1994. What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet 10:16-21.
16. Kitten AM, Lee JC, Olson MS. 1995. Osteogenic protein-1 enhances phenotypic expression in ROS 17/2.8 cells. Am J Physiol Endocrinol Metab 32 269:E918-E926.
17. Knutsen R, Wergedal JE, Sampath TK, Baylink DJ, Mohan S. 1993. Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Biochem Biophys Res Commun 194:1352-1358.
18. Knutsen R, Honda Y, Strong DD, Sampath TK, Baylink DJ, Mohan S. 1995. Regulation ofinsulin-like growth factor system components by osteogenic protein-1 in human bone cells. Endocrinology 136:857-865.
19. Lemonnier J, Ghayor C, Guicheux J, Caverzasio J. 2004. Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation ofstress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation. J Biol Chem 279:259-264.
20. Liu P, Scharenberg AM, Cantrell DA, Matthews SA. 2007. Protein kinase D enzymes are dispensable for proliferation, survival and antigen receptor-regulated NFkappaB activity in vertebrate B-cells. FEBS Lett 581:1377-1382.
21. Matthews SA, Liu P, Spitaler M, Olson EN, Mc Kinsey TA, Cantrell DA, Scharenberg AM. 2006. Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Cell Biol 26:1569-1577.
22. Mc Carthy TL, Centrella M, Canalis E. 1988. Furtherbiochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 3:401-408.
23. Nakayama Y, Nakajima Y, Kato N, Takai H, Kim DS, Arai M, Mezawa M, Araki S, Sodek J, Ogata Y. 2006. Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene. J Cell Physiol 208:326-335.
24. Ozkaynak E, Rueger DC, Drier EA, Cobett C, Ridge RJ, Sampath TK, Oppermann H. 1990. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J 9:2085-2093.
25. Reddi AH. 2000. Bone morphogenetic proteins and skeletal development: The kidney-bone connection [In Process Cita-tion]. Pediatr Nephrol 14:598-601.
26. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH. 1992. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267:20352-20362.
27. Shoba LN, Lee JC. 2003. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells. J Cell Biochem 88:1247-1255.
28. Srinivasan N, Knutsen R, Baylink DJ, Sampath TK, Mohan S. 1995. Evidence that TGF-β, and BMP-7 increase insulin-like growth factor binding protein (IGFBP)-3 production via different protein kinase-C-dependent signal transduction path-ways in human bone cells. J Bone Miner Res 10(Suppl 1):S310.
29. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. 1995. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270:9420-9428.
30. Storz P, Doppler H, Johannes F, Toker A. 2003. Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J Biol Chem 278:17969-17976.
31. Storz P, Doppler H, Toker A. 2004. Protein kinase C delta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. Mol Cell Biol 24: 2614-2626.
32. Wang QJ. 2006. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 27:317-323.
33. Wang D, Yu X, Brecher P. 1998. Nitric oxide and N-acetylcysteine inhibit the activation of mitogen-activated protein kinases by angiotensin II in rat cardiac fibroblasts. J Biol Chem 273: 33027-33034.
34. Wozney JM, Rosen V. 1998. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 346:26-37.
35. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, Le Roith D. 2002. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781.
36. Yakar S, Bouxsein ML, Canalis E, Sun H, Glatt V, Gundberg C, Cohen P, Hwang D, Boisclai Y, Leroith D, Rosen CJ. 2006. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J Endocrinol 189:289-299.
37. Yeh LC, Lee JC. 2006. Co-transfection with the osteogenic protein-1 gene and the insulin-like growth factor-I gene enhanced osteoblastic cell differentiation. Biochim Biophys Acta 1763:57-63.
38. Yeh LC, Adamo ML, Kitten AM, Olson MS, Lee JC. 1996. Osteogenic protein-1-mediated IGF gene expression in primary cultures of rat osteoblastic cells. Endocrinology 137:1921-1931.
39. Yeh LC,Adamo ML, Olson MS, Lee JC. 1997. Osteogenicprotein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138:4181-4190.
40. Yeh LC, Unda R, Lee JC. 2000. Osteogenic protein 1 differentially regulates the mRNA expression ofbone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol 185:87-97.
41. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL. 2002. Osteoblast-specific knockout growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.